Part B Drugs – MedPAC

An official website of the United States Government —

Here’s how you know

MedPAC > Our Work > Part B Drugs

Part B Drugs

Showing 1 - 10 out of 175

Nov 03, 2021 / Payment Basics

Part B drugs payment systems

Research Areas:

Drugs, Devices, and Tests

Oct 07, 2021 / Presentations

Addressing high prices of pharmaceutical products (and other technologies) covered under Medicare

Research Areas:

Drugs, Devices, and Tests

Oct 07, 2021 / Presentations

Data on Medicare’s net prices for prescription drugs and other drug pricing metrics

Research Areas:

Drugs, Devices, and Tests

Sep 09, 2021 / Comment Letters

MedPAC comment on CMS’s proposed rule on CY 2022 revisions to payment policies under the physician fee schedule and other changes to Part B payment policies

Research Areas:

Ambulatory Care Settings, Delivery System Reforms, Quality

Jul 05, 2021 / Data Book

July 2021 Data Book: Health Care Spending and the Medicare Program

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2021 / Press Releases

MedPAC releases June 2021 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2021 / Reports

June 2021 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2021 / Chapters

Chapter 8: Improving Medicare’s policies for separately payable drugs in the hospital outpatient prospective payment system (June 2021 report)

Research Areas:

Drugs, Devices, and Tests, Hospitals

Jun 15, 2021 / Chapters

Executive summary (June 2021 report)

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues